97 results on '"Nout, Remi A"'
Search Results
2. Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy
3. Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation
4. Predictive Factors for Toxicity After Primary Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review
5. 127 Impact of Brachytherapy Applicator on Clinical Outcomes in Cervix Cancer: An EMBRACE-I Study Analysis
6. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer
7. Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma
8. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
9. ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
10. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer
11. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer
12. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
13. GEC-ESTRO (ACROP)–ABS–CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina
14. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts
15. Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE–I study
16. Brachytherapy training survey among radiation oncology residents in Europe
17. Postgraduate education in radiation oncology during the COVID-19 pandemic – What did we learn?
18. Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study
19. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
20. Multi-center analysis of machine-learning predicted dose parameters in brachytherapy for cervical cancer
21. Risk Factors for Late Persistent Fatigue After Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: An Analysis From the EMBRACE-I Study
22. Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile
23. A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer
24. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
25. Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment
26. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
27. Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
28. Interpretable Deep Learning Predicts the Molecular Endometrial Cancer Classification from H&E Images: A Combined Analysis of the Portec Randomized Clinical Trials
29. Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors
30. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review
31. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
32. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study
33. Uterine serous carcinoma
34. Highlights from the recent 2020 Annual Global IGCS Meeting
35. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
36. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis
37. Response to Yuce Sari et al.
38. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
39. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study
40. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial
41. Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network
42. Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study
43. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
44. Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer
45. Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer
46. Education and training for image-guided adaptive brachytherapy for cervix cancer—The (GEC)-ESTRO/EMBRACE perspective
47. Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer
48. Implementing an online radiotherapy quality assurance programme with supporting continuous medical education – report from the EMBRACE-II evaluation of cervix cancer IMRT contouring
49. Recommendations from gynaecological (GYN) GEC-ESTRO working group – ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer
50. Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.